How to buy ARM Holdings (ARM) stock from India

Yes, an Indian resident can buy ARM Holdings — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% is tax, estate-tax exposure, position sizing, and the fact that ARM trades on a thin float with one giant owner overhead.

The 30-second version

• Legal and simple. Buy ARM via any India-facing platform (Vested, INDmoney) or a global broker (IBKR, Rovia). Whole shares or a fractional rupee amount.
• Almost pure capital-gains story. ARM pays no meaningful dividend — US dividend withholding is a non-issue. Your return is the price move, and the price move is large.
• India tax: hold more than 24 months → 12.5% LTCG (no indexation); sell sooner → your slab rate. Section 112, not the friendlier 112A Indian-listed shares get.
• The trap most miss: directly-held ARM is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no treaty relief.
• If your thesis is "AI and semis," QQQ and many semi ETFs already hold ARM — broader exposure, no single-stock risk, no float-overhang surprise.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	ARM / Nasdaq
IPO	September 2023
Free float	Low — SoftBank still holds roughly 85-90%
How	IBKR, Rovia, INDmoney, or Vested
Minimum	A fraction of one share
Dividend	None / token — withholding negligible
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k → up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Use IBKR for the widest access and best execution, Rovia for a combined RSU + LRS experience, or INDmoney / Vested for a simple India-funded flow.
2. Fund it via the LRS. Remit under the LRS (cap: $250,000 per financial year). 20% TCS applies above ₹10 lakh in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator. For the full compliance picture, see the LRS + TCS + Schedule FA trifecta.
3. Place the order. Whole shares work on most India-facing platforms, but fractional orders are the cleanest way to size an exact rupee amount.

The tax that actually matters

ARM pays no real dividend, so the 25% dividend-withholding hassle is irrelevant. This is a capital-gains story, taxed under Section 112 (foreign shares don't get the Section 112A treatment Indian equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to ≈30%+)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 10 shares at $120 when USD/INR is 93 → cost ₹1,03,200. Sell 26 months later at $170 when USD/INR is 95 → proceeds ₹1,49,600. Gain ₹46,400; LTCG at 12.5% = ₹5,800. Gains are computed in rupees, so currency is baked in. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India. The India-US tax treaty (DTAA) guide covers dividend withholding relief and treaty benefits. Dividend mechanics, for completeness, are in Form 67 and US dividend withholding.

The $60,000 estate-tax trap

Directly-held ARM is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. The most under-appreciated risk in direct US holding; the fix (pooled or fund structures instead of direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get ARM through an ETF?

If you want…	Best route
A concentrated bet on ARM's royalty flywheel	ARM directly
"AI and semis will keep winning" exposure	A semis or Nasdaq-100 ETF — ARM is in there, plus everyone else
The least single-stock risk	A broad ETF

ARM is in QQQ and several semi and tech ETFs, and its index weight has been creeping up since the IPO as more float gets distributed. If your thesis is "the chip-IP layer keeps compounding," an ETF gives you ARM plus its customers in one wrapper. Compare routes in direct stocks vs US ETFs and best US ETFs for Indian investors; broader case in US ETFs for Indians.

The business in one screen

What it is: ARM designs the CPU instruction-set architecture and core IP that virtually every smartphone runs on. It doesn't make chips — it licenses designs and earns a royalty on every chip shipped. High-margin, recurring, tied to global chip volumes.

Bull case	Bear case
Near-monopoly in smartphone CPU IP; royalties compound with units shipped	Extreme valuation — among the richest forward multiples in mega-cap semis
Expanding into data center (Neoverse, AWS Graviton, Nvidia Grace), automotive, AI PCs	Very low free float; SoftBank overhang is a real flow risk
Royalty model: high gross margin, secular volume growth	RISC-V (open, royalty-free instruction set) is a credible long-term competitor
	Royalty base still leans on smartphones; cyclical and concentrated

Exact valuation is in the live widget above — an exceptional business priced for many years of perfect execution.

Our take

Verdict: BUY — ARM's royalty model is structurally benefiting from the AI infrastructure build-out in a way that wasn't fully priced at IPO. Every AI server ships Arm-based management CPUs, every AI PC runs Arm ISA, and hyperscaler custom silicon (Apple, AWS Graviton, Google Axion, Microsoft Cobalt) all license ARM architecture. The royalty rate per chip is rising as complexity increases.

• The AI data-centre win is structural. Arm-based CPUs now run significant portions of AWS, Google Cloud, and Microsoft Azure's compute fleet. Custom silicon by the hyperscalers — all ARM-licensed — reduces dependence on x86 and increases ARM's total addressable royalty base materially.
• Royalty rate uplift is underappreciated. ARM charges royalties as a percentage of chip selling price, and the move to advanced nodes (N3, N2) for AI chips means higher ASPs per chip, which mechanically lifts royalties even at flat unit volumes.
• The float overhang has partly cleared. SoftBank has sold down its stake through secondaries since IPO. The overhang is reduced; remaining lockup dynamics are less acute.
• The multiple is still demanding. A single soft quarter, slower hyperscaler ramp, or credible RISC-V displacement in cost-sensitive markets can compress the stock sharply. Size as a focused satellite with high conviction, not a core allocation.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Valuation: at this multiple, even a strong year can deliver a flat or negative price outcome.
• Float and overhang: low liquidity plus the SoftBank stake drives moves bigger than fundamentals suggest.
• Architecture risk: RISC-V adoption in data center and embedded is the most underrated long-term bear case.
• Customer concentration: smartphone royalties still anchor the model; a weak handset cycle hits the top line.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose ARM in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Schedule FA helper.
• Position size: a low-float, high-multiple single name is not an index. Size it as a conviction bet, not a core holding.

Bottom line

Buying ARM from India is easy and legal. What needs thought isn't the buying — it's that ARM is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap, and a low-float, premium-multiple single name with a structural overhang. If your real thesis is "the chip-IP layer keeps compounding," an ETF gives you exposure without the concentration. Full picture at the US investing hub.

Related stocks and ETFs to consider

Indian investors researching Arm Holdings often also look at:

• NVIDIA from India — the leading AI accelerator chipmaker
• AMD from India — NVIDIA's closest GPU and CPU competitor
• ASML from India — the monopoly maker of EUV lithography machines
• Semiconductor stocks after the rally (June 2026) — our latest take on the sector
• SOXX semiconductor ETF from India — diversified semiconductor exposure

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.